Furthermore, NKG2D-CAR T cells were effective against tumors with heterogeneous ligand expression (33) and NKG2D-CAR-expressing NK cells eradicated myeloid suppressor cells in the tumor microenvironment of solid tumors (34). This evidence concerns the gene KLRK1 and neoplasm.